Aglaia Schiza

7PUBLICATIONS
7CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Women's studies (incl. girls' studies)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 12, 2026
Immune checkpoint inhibitor treatment - real-world use and outcomes in Sweden 2015-2023.

|May 13, 2026
Endocrine therapy and COVID-19 outcomes in women with breast cancer: a nationwide register- based matched cohort study.

|May 19, 2024
Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study.

Carina Strell, Daniel Robert Smith, Antonis Valachis

|Oct 09, 2023
Treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study.

Aglaia Schiza, Irma Fredriksson, Malin Sund

|Jul 25, 2023
De novo metastatic breast cancer in men vs women: a Swedish population-based cohort study.

Aglaia Schiza, Irma Fredriksson, Malin Sund

|Dec 01, 2020
Predictive role of HER2-status on the effectiveness of endocrine adjuvant treatment in postmenopausal breast cancer patients: a population-based cohort study.

Aglaia Schiza, Davide Mauri, Irma Fredriksson

Pageof 2

Frequent Collaborators

1 joint publications

Angelica Loskog

1 joint publications

Irma Fredriksson

1 joint publications

Malin Sund

1 joint publications

Kristoffer Illergard